Tradewinds Capital Management, LLC Bio N Tech Se Transaction History
Tradewinds Capital Management, LLC
- $371 Million
- Q1 2025
A detailed history of Tradewinds Capital Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 177 shares of BNTX stock, worth $18,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
177
Previous 117
51.28%
Holding current value
$18,004
Previous $13,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$830 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$433 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$412 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$193 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$184 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...